Skip to content

Clinical safety and efficacy trial of benign paroxysmal positional vertigo (BPPV) diagnosis and treatment system for the treatment of BPPV

Clinical safety and efficacy trial of benign paroxysmal positional vertigo (BPPV) diagnosis and treatment system for the treatment of BPPV

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17010506
Enrollment
Unknown
Registered
2017-01-23
Start date
2017-09-01
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign paroxysmal positional vertigo

Interventions

Group 1:Bedside canalith repositioning maneuver
Group 2:Chair assisted canalith repositioning maneuver

Sponsors

Shanghai Sixth people’s hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1.Older than 18 years old, either sex; 2.Unilateral BPPV diagnosed (unilateral BPPV with single semisirclr canal involved); 3.Participant can understand the trial, and sign the RTF

Exclusion criteria

Exclusion criteria: 1.The course of BPPV duration less than 3 days or longer than 3 months; 2.With a serious disease such as the cervical spine, bone fracture and brain injury, the acute period of vertigo attack; 3.Contraindications to the product; 4.With severe cardiovascular disease or organ failure; 5.Nursing mothers or pregnant women; 6.Participate in other clinical trials within the last 3 months.

Design outcomes

Primary

MeasureTime frame
Effective rate at 1-week follow-up;

Secondary

MeasureTime frame
effective and curative rate immediately after treatment;curative rate at 1-week follow-up;effective and curative rate at 2-week follow-up;effective and curative rate at 3-week follow-up;effective and curative rate at 4-week follow-up;

Countries

China

Contacts

Public ContactHaibo Shi

Shanghai Sixth People's Hospital

haibo99@hotmail.com+86 21 2405 8706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 12, 2026